World leaders are increasingly terrified that drug-resistant superbugs are a 'major global threat'

World leaders gather at the U.N.
(Image credit: Getty Images)

The growing threat of antibiotic-resistant superbugs prompted global leaders to meet Wednesday for only the fourth time ever about a health-related topic. In a meeting during this week's United Nations General Assembly, heads of state together with global health and agriculture groups acknowledged that antimicrobial resistance is a growing threat that requires prompt attention. "It's not that it may happen in the future, it's a very present reality," said U.N. Secretary General Ban Ki-moon. The only other health topics U.N. leaders have met to discuss are the AIDS crisis (in 2001), chronic illnesses (in 2011), and the Ebola epidemic (in 2014).

By the year 2050, it's estimated that 10 million people will die annually because of antibiotic-resistant infections. Scientists are particularly concerned about the increased antibacterial resistance of sexually transmitted diseases, including HIV, and the similar threat posed by malaria. "Some scientists call it a slow-motion tsunami. The situation is bad and getting worse," said Dr. Margaret Chan, director general of the World Health Organization.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us